Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases

Spondyloarthritis (SpA) and inflammatory bowel diseases (IBD) are chronic inflammatory diseases characterized by an aberrant immune response and inflammation with a key role for TNF in their pathogenesis. Accordingly, TNF-inhibiting therapy (TNFi) has dramatically improved the management of these di...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Laganà, Bruno, Zullo, Angelo, Scribano, Maria Lia, Chimenti, Maria Sole, Migliore, Alberto, Picchianti Diamanti, Andrea, Lorenzetti, Roberto, Scolieri, Palma, Ridola, Lorenzo, Ortona, Elena, Pierdominici, Marina, Bruzzese, Vincenzo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2019
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360251/
https://ncbi.nlm.nih.gov/pubmed/30745872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00047
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller